Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

10,483 11,387

Prepaid expenses and other current assets 3,600 4,729

Total current assets 89,690 87,883

Property and equipment, less accumulated

depreciation and amortization of $6,848

and $6,155, respectively 1,186 1,369

Goodwill 27,313 27,313

Acquired/developed software, less accumulated

amortization of $7,992 and $6,035, respectively 8,008 7,665

Other intangible assets, less accumulated

amortization of $1,742 and $1,316, respectively 1,658 2,084

Other assets 586 557

Total Assets $128,441 $126,871

Liabilities and stockholders' equity

Current liabilities:

Accounts payable and accrued expenses $9,820 $8,052

Deferred revenue, including unearned

discounts of $0 and $336, respectively 10,375 10,867

Total current liabilities 20,195 18,919

Other liabilities, primarily unearned discounts

re: outsourced printing services - 397

Commitments and contingencies

Stockholders' equity:

Preferred stock $.001 par value; 2,000,000

shares authorized; none issued - -

Common stock $.001 par value, 200,000,000 shares

authorized, 51,296,823 and 51,066,966 issued,

respectively 51 51

Additional paid-in capital 229,056 226,764

Accumulated other comprehensive 60 (4)

income

Accumulated deficit (98,478) (97,616)

Treasury stoc
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 2Health News:Caldwell College to Host National Conference on Autism and Applied Behavior Analysis in April, Autism Awareness Month 3Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 2Health News:Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus 3Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 2Health News:American Kidney Fund Warns of Kidney Disease Risk Factors During Kidney Awareness Month 3Health News:Guy's and St Thomas' NHS Foundation Trust extends patient care benefits of BigHand Digital Dictation 2Health News:Blue Highway Selects Invention Machine Goldfire to Fuel Product Pipeline and Sustain Breakthrough Innovation 2Health News:Blue Highway Selects Invention Machine Goldfire to Fuel Product Pipeline and Sustain Breakthrough Innovation 3
Breaking Medicine Technology:Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 1Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 2Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 3Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 4Three New Studies Give Clear Guidance on How to Better Recruit Volunteers for Alzheimers Clinical Studies 51407 5Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 1Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 2Brooks Instrument Introduces New Liquid Vaporizer Solutions Breakthrough Vaporization Solutions for All Liquid to vapor Applications 51402 3Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 9225 1Federal Bureau of Investigation Awards Lockheed Martin Biometric Card Scanning Service Contract 9225 2
Other Medicine Technology:Argos Therapeutics Presents Immunosuppression Data for Soluble CD83,at the American Society of Transplantation Congress 2007 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12